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Abstract
Background: The WHO recommends exclusive breastfeeding (EBF) for the first 6 mo of life.
Objective: The objective of this study was to assess the benefit of EBF to age 6 mo on growth in a large sample of rural
Gambian infants at high risk of undernutrition.
Methods: Infants with growth monitoring from birth to 2 y of age (n = 756) from the ENID (Early Nutrition and Immune
Development) trial were categorized as exclusively breastfed if only breast milk and no other liquids or foods were given.
EBF status was entered into confounder-adjusted multilevel models to test associations with growth trajectories by using
>11,000 weight-for-age (WAZ), length-for-age (LAZ), and weight-for-length (WLZ) z score observations.
Results: Thirty-two percent of infants were exclusively breastfed to age 6 mo. The mean age of discontinuation of EBF
was 5.2 mo, and growth faltering started at;3.5 mo of age. Some evidence for a difference in WAZ and WHZ was found
between infants who were exclusively breastfed to age 6 mo (EBF-6) and those who were not (nEBF-6), at 6 and 12 mo of
age, with EBF-6 children having a higher mean z score. The differences in z scores between the 2 groups were small in
magnitude (at 6 mo of age: 0.147 WAZ; 95% CI: 20.001, 0.293 WAZ; 0.189 WHZ; 95% CI: 0.038, 0.341 WHZ). No
evidence for a difference between EBF-6 and nEBF-6 infants was observed for LAZ at any time point (6, 12, and 24 mo of
age). Furthermore, a higher mean WLZ at 3 mo of age was associated with a subsequent higher mean age at
discontinuation of EBF, which implied reverse causality in this setting (coefficient: 0.060; 95% CI: 0.008, 0.120).
Conclusion: This study suggests that EBF to age 6 mo has limited benefit to the growth of rural Gambian infants. This trial
was registered at http://www.isrctn.com as ISRCTN49285450. J Nutr doi: 10.3945/jn.116.241737.
Keywords: exclusive breastfeeding, infant feeding practice, postnatal growth, The Gambia, multilevel modelling,
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Introduction
The WHO recommends exclusive breastfeeding (EBF)8 for the
first 6 mo of an infants life, with continued breastfeeding up to
2 y of age or beyond, along with nutritionally adequate, safe, and
appropriate complementary foods (1). Optimal breastfeeding
practices have been shown to have clear short-term advantages
for child morbidity and mortality, especially in low- and middle-
income countries (LMICs) (2). A systematic review that supports
the EBF recommendation analyzed several studies from low-,
middle-, and high-income countries and reported that EBF to
6 mo of age compared with EBF to 3–4 mo of age with continued
mixed breastfeeding (introduction of complementary liquids or
8 Abbreviations used: EBF, exclusive breastfeeding; EBF-6, exclusively
breastfed to age 6 mo (group designation); ENID, Early Nutrition and Immune
Development; LAZ, length-for-age z score; LMIC, low- and middle-income
country; MLM, multilevel model; MRC, Medical Research Council; nEBF-6, not
exclusively breastfed to age 6 mo (group designation); WAZ, weight-for-age z
score; WLZ, weight-for-length z score.
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solid foods) resulted in lower morbidity from gastrointestinal
infection and prolonged lactational amenorrhea (3).
In many LMICs, infants are small at birth, show catch-up
growth in the first few months of life, and then enter a period of
reduced growth velocity, which results in substantial growth
faltering by the second year of life (4, 5). The growth faltering
usually begins within the first 6 mo of life (4–7). However, there
is limited evidence as to how EBF to 6 mo affects infant growth.
The majority of studies were conducted in affluent countries or
urban areas in LMICs, where overweight and obesity is a greater
problem than growth faltering and where nonexclusively
breastfed children are often or usually given infant formula (8–
12). A growing number of trials that randomly assigned mothers
to EBF counseling have been implemented in low-income
settings (13–17); however, only 2 trials investigated the effect
that EBF to age 6 mo has on growth in settings in which no
infant formula was consumed (13, 14). In these 2 studies, both
conducted in Honduras, there was no difference in weight or
length at 6 mo of age between infants who were exclusively
breastfed to 6 mo compared with to 4 mo (with continued
breastfeeding and solid foods). These studies were, however,
criticized for having a low sample size (n = 119 and n = 97,
respectively) (3), and only 1 of these trials followed the infants to
1 y of age (13). Observational studies from LMICs have also
investigated this topic and found similar results, that EBF to
6 mo has limited benefit to growth (18, 19). However, the
majority of the observational studies were either cross-sectional
or longitudinal studies that analyzed serial measurements as
cross-sectional data, which reduces the power of longitudinal
data (20).
The Gambia is a low-income country in West Africa, where
food availability and nutritional status in rural areas are poor. A
FIGURE 1 Flow diagram of included
and excluded participants in the ENID
trial and in this analysis. ENID, Early
Nutrition and Immune Development;
hCG, human chorionic gonadotropin;
SAM, severe acute malnutrition.
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large proportion of children in this setting experience substantial
growth faltering (5) and women are at great risk of several
micronutrient deficiencies (21). Furthermore, in rural areas,
food availability and nutritional status are strongly influenced
by seasonality, and a chronically marginal diet is exacerbated
by a ‘‘hungry season,’’ when food stocks from the previous
harvest season are depleted (22). In this analysis, we used
longitudinal data on growth and infant feeding practices for 756
infants from rural Gambia to investigate whether following the
WHO EBF recommendation is associated with better growth
from birth to 2 y of age.
Methods
Study population. The current analysis used data collected as part of
the Early Nutrition and Immune Development (ENID) Study, a randomized
trial conducted in the West Kiang region of The Gambia between April
2010 and February 2015. The current post hoc analysis was not planned
in the original study design. Full details of the main ENID trial can be
found in the published trial protocol (23). The main trial followed
pregnant women and their infants to 1 y of age; however, here we
additionally used data from the ENID-Growth Study, which is an
extension of the main ENID trial, in which follow-up of infants was
continued to 2 y of age. Briefly, women of reproductive age (18–45 y) were
recruited to assess the effect of combined prenatal and infant nutritional
supplementation on infant immune development. Pregnant women were
randomly assigned, in a partially blinded fashion, to a supplement group
when they booked for antenatal care (before 20 wk of gestation), with
supplementation continuing until delivery. Nurses, midwives, and field-
and community health workers were trained in optimal breastfeeding
practices; however, no counseling to the participating women was
implemented beyond what is standard practice in this baby-friendly
community. The women were randomly assigned to one of the following
intervention arms: 1) iron + folic acid, 2) multiple micronutrients,
TABLE 1 Description of study population according to infant feeding practice1
Variable n
Exclusively breastfed to
age 6 mo
Not exclusively breastfed to
age 6 mo All
Maternal age, y 755 29.9 6 6.4 30.4 6 6.9 30.3 6 6.9
Maternal weight, kg 755 55.3 6 9.4 55.7 6 9.6 55.6 6 9.5
Maternal height, cm 756 161.7 6 5.7 162.1 6 5.9 162.0 6 5.8
Maternal BMI, kg/m2 755 21.2 6 3.6 21.2 6 3.3 21.2 6 3.4
Parity categories, n (%)
Primiparous 88 32 (13.5) 56 (10.8) 88 (11.6)
Multiparous 668 206 (86.5) 462 (89.2) 668 (88.4)
Maternal education categories, n (%)
No education 591 192 (80.7) 399 (77.0) 591 (78.2)
Low education (1–7 y) 94 25 (10.5) 69 (13.3) 94 (12.4)
Medium education (8–14 y) 71 21 (8.8) 50 (9.7) 71 (9.4)
Maternal supplementation categories, n (%)
Fe-Fol 191 66 (27.7) 125 (24.1) 191 (25.3)
MMNs 194 55 (23.1) 139 (26.8) 194 (25.7)
PE + Fe-Fol 179 63 (26.5) 116 (22.4) 179 (23.7)
PE + MMNs 192 54 (22.7) 138 (26.6) 192 (25.4)
Birth weight, kg 629 3.045 6 0.4 3.005 6 0.4 3.017 6 0.4
Birth-weight categories, n (%)
Low (,2.5 kg) 53 14 (7.2) 39 (9.0) 53 (8.4)
Normal (2.5–3.9 kg) 572 179 (91.8) 393 (90.6) 572 (90.9)
High ($4.0 kg) 4 2 (1.0) 2 (0.5) 4 (0.6)
Birth length, cm 751 50.5 6 2.1 50.7 6 2.1 50.6 6 2.1
WAZ at birth 629 20.55 6 0.9 20.64 6 0.9 20.62 6 0.9
LAZ at birth 751 20.62 6 1.0 20.50 6 1.0 20.54 6 1.0
WLZ at birth 746 20.55 6 1.1 20.77 6 1.1* 20.70 6 1.1
Gestational age at birth, wk 750 40.1 6 1.4 40.2 6 1.6 40.2 6 1.6
Gestational age categories, n (%)
,37 wk 20 7 (3.0) 13 (2.5) 20 (2.7)
37–40 wk 315 104 (44.4) 211 (40.9) 315 (42.0)
.40 wk 415 123 (52.6) 292 (56.6) 415 (55.3)
Infant season of birth categories, n (%)
Wet season (June–October) 290 90 (37.8) 200 (38.6) 290 (38.4)
Dry season (November–May) 466 148 (62.2) 318 (61.4) 466 (61.6)
Infant diarrhea episodes (in the first 2 y of life), n 756 4.5 6 3.8 4.2 6 3.3 4.3 6 3.5
Infant morbidity episodes (in the first 2 y of life), n 756 16.4 6 8.7 16.3 6 8.3 16.4 6 8.4
Village categories, n (%)
From Jali, Kantong Kunda, Keneba, or Manduar 194 43 (18.1) 151 (29.2)* 194 (25.7)
From remaining villages 562 195 (81.9) 367 (70.9) 562 (74.3)
1 Values are means 6 SDs unless otherwise indicated. *Different from infants exclusively breastfed to age 6 mo, P # 0.05. Fe-Fol, iron +
folic acid; LAZ, length-for-age z score; MMN, multiple micronutrient; PE, protein-energy; WAZ, weight-for-age z score; WLZ, weight-for-
length z score.
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3) protein-energy and iron+folate, or 4) protein-energy and multiple
micronutrients. Their infants were further randomly assigned from 6 to 18
mo of age to a supplement group of lipid-based nutritional supplements
fortified with multiple micronutrients or to a group of lipid-based
nutritional supplements and followed up to 2 y of age. A total of 2798
women consented to the ENID study, and of these, 875 were eligible for
supplementation. The infants were born between August 2010 and
February 2014, and 756 infants were included in this analysis (Figure 1).
Anthropometric measurements. Infants had anthropometric mea-
surements taken at birth (within 72 h of delivery) and at scheduled visits
to the Medical Research Council (MRC) Keneba field station at 1, 8, 12,
24, 52, 78, and 104 wk of age, with additional home visits at 16, 20, 32,
40, 65, and 91 wk by trained fieldworkers. An embedded substudy
measured;200 infants at the additional time points of 4, 28, 36, 44, and
48 wk of age with the use of the same procedures and anthropometric
equipment as the main follow-up (see Supplemental Table 1 for data
availability according to time point). All weights and lengths were
measured by using electronic scales and length boards, which were
precise to 10 g and to 1 mm, respectively. Fixed-length boards (Seca 417)
were used for all clinic and field visits after the neonatal home visit, for
which a flexible-length mat was used. Weight and length measurements
were converted to weight-for-age z score (WAZ), length-for-age z score
(LAZ), and weight-for-length z score (WLZ) according to the WHO
growth standards by using the WHO Anthro program (version 3.2.2;
January 2011). The data set consisted of >11,100 assessments of WAZ,
LAZ, and WLZ, with a mean of 14.8 assessments/infant (range: 2–19
assessments) over a mean of 23 mo (range: 0.2–25 mo).
Infant feeding practice and morbidity data. Trained fieldworkers
collected weekly infant feeding and morbidity data by questionnaire at
home visits. At these visits, the mother or caregiver was asked to recall
infant feeding practices in the previous 7 d (i.e., if the infant was
breastfed, and if other foods or drinks had been introduced, and the
frequency of these other foods and/or drinks). The mother or caregiver
was further asked if the child had experienced any diarrhea, vomiting,
cough, rapid breathing, or fever in the past 7 d.
Exposure and confounding variables. Infant feeding practice was
defined as being exclusively breastfed to age 6 mo (EBF-6; provision of
breast milk only) compared with not being exclusively breastfed to age
6 mo (nEBF-6). The nEBF-6 infants were either predominantly breastfed
(provision of breast milk and liquids only) or partially breastfed
(provision of breast milk and solid foods) in the first 6 mo.
The following variables were investigated as potential confounders or
effect modifiers: maternal age, parity, weight (measured in the first
trimester of pregnancy), height, BMI, educational level (completed years of
either English or Arabic schooling), supplementation group during
pregnancy, village, gestational age at birth, and incidence of infant diarrhea
(defined as having $3 loose stools/d) and morbidity (defined as combined
episodes of diarrhea, vomiting, cough, rapid breathing, or fever).
‘‘Village’’ was defined as participants from 1 of the 4 ‘‘core’’ villages
of Jali, Kantong Kunda, Keneba, and Manduar compared with partic-
ipants from 1 of the remaining 24 villages. This division was chosen
because the core villages are situated close to the MRC Keneba field
station and therefore are in closest proximity to the MRC Keneba clinic,
which has a known influence on health-seeking behavior (24).
Statistical analysis. The crude association between infant feeding
practice and continuous data was investigated by using t tests; for
categorical data, chi-square tests were used. Multilevel models (MLMs)
were used for the analysis of longitudinal data. Individual age-related
trajectories for each of WAZ, LAZ, and WLZ were modeled separately
in an MLMwith measurement occasion at level 1; individuals at level 2;
incorporating infant feeding practice associations with the sample-mean
growth trajectories and adjustment for confounders and competing
effects.
The shape of each trajectory was specified as a restricted cubic spline,
with 4 knots (0.008, 0.389, 0.797, and 1.993 y). This model was chosen
because it provided the lowest deviance compared with quadratic, cubic,
and fractional polynomial growth-curve models. The constant and the
cubic spline age terms were allowed to have a random effect at level 2,
allowing deviations from the intercept and gradient of the mean
trajectory for each infant. Infant feeding practice was entered as follows:
1) as a main effect, representing the association of infant feeding practice
with the outcome at the intercept (i.e., at birth), and 2) as an interaction
with the spline age terms, representing its association with the slope or
rate of change in WAZ, LAZ, and WLZ. We used an unstructured
variance-covariance matrix for the level 2 random effects.
Seasonality of infant anthropometric measurements was included in
the MLMs with the use of Fouriers term (25). The Fourier series is a
statistical model that allows the decomposition of any periodic function
into a linear combination of simple oscillating functions (sines and
cosines) parameterized by coefficients (the Fourier coefficients) (25). In
this analysis, the first 4 sets of Fourier terms were used. Infant morbidity
incidence was added to the model as a time-dependent variable, and the
rest of the potential confounding and competing effect variables were
added as time-independent variables (for the full-model equation, see the
Supplemental Appendix).
Overall model fits were improved by removing all length measure-
ments at birth because residuals were large, assumedly due to high
measurement error. Birth measurements of length were often taken in the
subjects home, and the use of a flexible-length mat likely introduced
error. Data with large level 1 residuals (defined as >2 or <22 z scores)
were removed because they were outliers and assumed to reflect large
measurement error (for WAZ, LAZ, and WLZ, n = 8, 28, and 71 data
points were removed, respectively). The final MLMs had residual SDs of
0.38, 0.49, and 0.58 z scores for WAZ, LAZ, and WLZ, respectively,
which indicates the overall goodness-of-fit of the models. As shown, the
WLZ data did not fit the cubic spline model as well as LAZ and WAZ,
FIGURE 2 Rural Gambian infants feeding practice by age.
FIGURE 3 Rural Gambian infants anthropometric measurements
by age. Values are means 6 SEs.
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however as WLZ includes 2 sources of measurement errors (in weight
and length), the residual SD is inevitably larger for this model compared
to WAZ and LAZ (20).
The fully adjusted models were used to estimate between–infant
feeding group differences at selected infant ages (0, 6, 12, and 24 mo),
which are presented with 95% CIs. Furthermore, trajectories were
plotted according to infant feeding practice. All of the statistical analyses
were performed with STATA version 14 (StataCorp).
Ethics, governance, and trial registration. The ENID and ENID-
Growth trials were approved by the joint Gambia Government/MRC
Unit, The Gambia Ethics Committee (projects SCC1126v2 and
L2010.77, respectively). Written informed consent was obtained from
all of the women before enrollment into the trial. The trial observed
Good Clinical Practice Standards and the current version of the Helsinki
Declaration. The ENID trial was registered as ISRCTN49285450.
Results
Maternal and infant characteristics. A total of 756 mothers
were included in the analysis, with a mean 6 SD age of 30.3 6
6.9 y (Table 1). The population was lean: 19% of the mothers were
underweight [BMI (in kg/m2) <18.5] and only 11% were either
overweight or obese (BMI$25) at enrollment into the study (mean
gestational age at enrollment: 13.7 wk). Educational levels were
low,with 78%ofwomen having received no formal education. The
756 infants included in this analysis were born with a mean 6 SD
birth weight of 3.017 6 0.4 kg, 8% had low birth weights
(<2.5 kg), and 22%were small for gestational age. In the first 2 y of
life, the mean number of episodes of diarrhea and other morbidity
were 4.3 6 3.5 and 16.4 6 8.4, respectively.
Infant feeding. Thirty-two percent of infants were still EBF at
6 mo of age. Nine percent of infants were given breast milk and
liquids only, and 59% were given breast milk accompanied by
food in the first 6 mo (Figure 2). The mean age for introducing
anything other than breast milk was 5.2 mo, resulting in 67% of
infants being exclusively breastfed to 5 mo of age.
Among all infants, 1% were given water at 1 mo of age,
which increased to 62% by 6 mo, and 1% were given semisolid
foods at 1 mo of age, which increased to 51% by 6 mo. Other
non–breast-milk foods introduced to infants <6 mo of age
included sugar water (in 2% of infants), tea (4%), cow milk
(3%), tinned milk (2%), powdered milk (5%), prepared
weaning foods (4%), and solid foods (5%), although these foods
were given on few occasions. No infant formula was given at any
time point. All of the infants received some breast milk at 1 y of
age, and 49% of infants were still breastfed at 2 y of age.
Infant feeding and postnatal growth. Infants were born with
low mean WAZ, LAZ, and WLZ of 20.62 6 0.9, 20.54 6 1.0,
and20.706 1.1, respectively (Table 1); and substantial growth
faltering was indicated in the first 2 y of life (Figure 3). Rapid
growth was observed in the first few weeks after birth; however,
growth faltering started at ;3.5 mo of age (Figure 3). WAZ,
LAZ, and WLZ declined to a mean6 SD of21.346 0.9 WAZ,
21.31 6 1.0 LAZ, and 20.93 6 0.9 WLZ at 2 y of age, by
which time 26% of infants were stunted (LAZ <22), 12% were
wasted (WLZ < 22), and 23% were underweight (WAZ <22).
Modeling infant z scores in the first 2 y according to infant
feeding practice and adjusting for potential confounders and
competing effects showed limited evidence for a difference in
growth between EBF-6 and nEBF-6 infants (Figure 4). We found
weak evidence to suggest that EBF-6 infants had a higher mean
FIGURE 4 WAZ, LAZ, andWLZ trajectories between birth and 24 mo
of age according to infant feeding practice. Trajectories are estimated
from the multilevel models presented in Supplemental Table 2 and
were adjusted for sex (female: referent), gestational age at birth, infant
morbidity (no incidence), maternal height, BMI, parity (primiparous), and
village (Jali, Kantong Kunda, Keneba, or Manduar), when applicable.
EBF-6, infants exclusively breastfed to age 6 mo; LAZ, length-for-age
z score; nEBF-6, infants not exclusively breastfed to age 6 mo; WAZ,
weight-for-age z score; WLZ, weight-for-length z score.
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WAZ, by 0.147 z scores, than did nEBF-6 infants at 6 mo of age
(95% CI: 20.001, 0.293 WAZs; P = 0.05), and for WLZ the
observed difference between the groups was 0.189 (95% CI:
0.038, 0.341 WLZs; P = 0.01). At 6 mo of age, there was no
difference in LAZ between EBF-6 and nEBF-6 infants (Table 2).
Investigating the long-term influence of EBF to age 6 mo, we
found weak evidence for a difference in mean WAZ between
the 2 groups at 1 y of age, at which time EBF-6 infants were
marginally heavier (a difference of 0.183 WAZs; 95% CI: 0.011,
0.354; P = 0.04) than nEBF-6 infants. A similar result was seen for
WLZ, with a difference of 0.189 z scores (95% CI: 0.005, 0.345
WLZs; P = 0.04) between the 2 groups at 1 y of age. By 2 y of age,
the difference in WAZ declined to 0.143 (95% CI: 20.002, 0.283
WAZs; P = 0.05) and for WLZ to 0.097 (95% CI: 20.047, 0.242
WLZs; P = 0.2). For LAZ, we found no difference between EBF-6
and nEBF-6 infants at any time point (Table 2).
Our multilevel models further showed no evidence for an
interaction between infant feeding practice and the spline age
terms, because infant feeding status was not associated with age-
related increases (slopes) in any of the outcomes. Seasonality
had a large, significant impact on infant z scores, and morbidity
incidence had a negative influence on infant WAZ and WLZ
(Supplemental Table 2). As a sensitivity analysis, we also modeled
growth from ages 6 to 24 mo according to infant feeding
practice—hence, after infant feeding practice was ascertained.
With this analysis, we observed results very similar to our initial
analysis, adding strength to our main findings (data not shown).
The difference in mean age at discontinuation of EBF between
the EBF-6 and nENF-6 groups was small (6.2 compared with
4.7 mo), and we therefore conducted an MLM analysis post hoc
with a different exposure variable: EBF to 6 mo (6 0.5 mo)
compared with EBF to 3–4 mo (6 0.5 mo) with continued mixed
feeding (introduction of complementary liquids or solid foods).
With the use of this new categorization of infant feeding practice,
the analysis showed no difference in LAZ between the 2 groups at
any time point. For WAZ and WLZ, there was a difference
between the 2 groups at 6 mo of age, with infants who were EBF
to 6 mo having a higher mean WAZ (by 0.216; 95% CI: 0.027,
0.404 WAZs; P = 0.03) and mean WLZ (by 0.289; 0.093, 0.485
WLZs; P = 0.004) than infants who were EBF to 3–4 mo
(Supplemental Table 3). However, these differences disappeared
at 1 and 2 y of age, suggesting no long-term benefit of EBF at 6 mo
of age on growth. Only 502 infants were included in this analysis,
with 130 (26%) being exclusively breastfed to age 3–4 mo.
We further explored the observed difference in WLZ at birth
according to feeding practice (Table 1, Figure 4). It was not
possible to explain this difference by environmental, maternal,
or infant characteristics; and we therefore tested the possibility
of reverse causality. The method proposed by Vail et al. (26) was
applied, including infants who were still EBF at 3 mo of age,
testing whether their mean weight, length, and z score changes
between 2 wk and 3 mo of age were associated with subsequent
age of discontinuation of EBF. The same analysis was conducted
in infants who were still EBF at 4 mo of age. We did not find that
growth, either poor or good, in the first 3 or 4 mo of life was
associated with when a mother stopped EBF (Supplemental
Table 4). The method proposed by Kramer et al. (27) was also
applied, and it was found that a higher mean WLZ at 3 mo of
age was associated with a subsequent higher mean age at
discontinuation of EBF (coefficient: 0.060; 95% CI: 0.008,
0.120; P = 0.03). No evidence for an association was found by
using WLZ at 4 mo of age or with the use of other growth
outcomes.
Discussion
Among rural Gambian infants in this study, 32% were exclu-
sively breastfed to 6 mo of age, and 67% to 5 mo of age, which
vastly exceeded estimates from other West African countries
(28). However, despite impressive EBF practices, substantial
growth faltering was observed before 6 mo of age in this
population. Low infant meanWAZ, LAZ, andWLZ at 2 y of age
were found in this study population, which is in line with
previous findings in this rural Gambian setting (5) and similar
to what has been found in other West African populations (29).
Furthermore, the differences in z scores between EBF-6 and
nEBF-6 infants were small in magnitude (<0.2 SDs) across all
time points in the first 2 y of life, which is far from a difference
of >0.67 SDs, which corresponds to crossing a major centile
band (30).
To date, to our knowledge, few published trials have
investigated how following the WHO recommendation of EBF
to 6 mo of age benefits growth in a low-income setting. We
found 2 controlled trials from Honduras (13, 14), in which
mothers were randomly assigned at 4 mo postpartum to either
continue EBF to 6 mo or to feed solid foods from 4 to 6 mo and
to continue breastfeeding. These data were re-analyzed by
Kramer and Kakuma (3), who found that EBF to age 6 mo
compared with EBF to age 4 mo did not improve infant weight
or length at 6 mo of age and subsequently (ages 6–12 mo).
Similar results were found in observational studies (18, 19).
Kramer and Kakuma (3) further re-analyzed growth data from 3
studies, 2 from Honduras and 1 from Senegal (2 trials and
1 observational study) (13, 14, 18), and found nonsignificant
higher meanWAZ, LAZ, andWLZ in infants at 6 mo of age who
were exclusively breastfed to age 6 mo compared with to age
4 mo. The data presented in this current analysis add to the
existing evidence of limited benefit of EBF to 6 mo of age on
growth in low-income settings.
TABLE 2 Associations of exclusive breastfeeding to age 6 mo with infant growth at different ages
Weight-for-age z score1 Length-for-age z score2 Weight-for-length z score1
Estimate3 95% CI P Estimate3 95% CI P Estimate3 95% CI P
At birth 0.093 20.040, 0.226 0.2 20.037 20.187, 0.114 0.6 0.166 20.008, 0.340 0.06
At age 6 mo 0.147 20.001, 0.293 0.05 20.006 20.137, 0.125 0.9 0.189 0.038, 0.341 0.01
At age 12 mo 0.183 0.011, 0.354 0.04 0.059 20.085, 0.203 0.4 0.175 0.005, 0.345 0.04
At age 24 mo 0.143 20.002, 0.283 0.05 0.095 20.047, 0.237 0.2 0.097 20.047, 0.242 0.2
1 Adjusted for sex, village, infant morbidity, gestational age at birth, parity, maternal height, and BMI.
2 Adjusted for sex, infant morbidity, gestational age at birth, parity, maternal height, and BMI.
3 The estimates show the difference in z score between infants who were exclusively breastfed to age 6 mo and infants who were not
exclusively breastfed to age 6 mo.
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In a post hoc analysis of our data, infants whowere exclusively
breastfed to age 6 mo had a higher meanWAZ andWLZ at 6 mo
of age than did infants who were exclusively breastfed to age
3–4 mo with continued mixed feeding. This difference, how-
ever, disappeared by 1 y of age. Changing the exposure variable
meant that a large proportion of infants (36%) were excluded
from the analysis, because they fell outside the new infant
feeding categorization.
An interesting observation is the difference in WLZ at birth
according to infant feeding practice. This observation could
reflect a consequence of somematernal, environmental, or infant
characteristic that determined both feeding practice and infant
size at birth. However, a detailed analysis of predictors did not
support this assumption. Second, this observation could reflect
reverse causality, with mothers in this community choosing to
continue EBF if their infant was growing well. Research from the
United Kingdom has shown that rapid weight gain between birth
and 3 mo of age predicted subsequent earlier age of weaning (26).
Kramer et al. (27) found contrary results: a low WAZ (<21) at
1 mo increased the risk of both weaning and discontinuation of
EBF by 2 mo of age in a Belarusian population. We did not find
evidence that weight gain or loss in the first 3 or 4 mo of life
predicted discontinuation of EBF; however, a higher mean WLZ
at 3 mo of age predicted subsequent higher age at discontinuation
of EBF. This could suggest that infant size influences EBF practice
in this setting and not vice versa. This possibility that larger
infants are more likely to remain exclusively breastfed reinforces
the conclusion that EBF to age 6 mo does not yield a growth
benefit.
An important strength of this study is the comprehensive
growth and feeding data collected prospectively. Infant feeding
data were collected weekly, which made it possible to determine
feeding practice accurately according to infant age. This further
allowed the use of multilevel modeling to analyze the data
longitudinally. However, we acknowledge several limitations.
First, this was an observational study, with well-recognized
sources of potential bias. Second, substantial error in the WLZ
model was observed, because WLZ combines 2 sources of error
(weight and length).
There are a number of possible reasons for the lack of a strong
association between early infant feeding practice and infant
growth in this rural Gambian population. First, there was a low
diversity in feeding behavior observed in this population. The
differences in feeding practice between the 2 groups were modest
and the population had a highmean age of discontinuation of EBF
(5.2 mo). Second, drivers of growth faltering in this setting are
potentially so powerful that EBF to age 6 mo is not sufficient to
improve growth over the long term. Several combined environ-
mental effects, such as a highly infectious disease environment,
food insecurity, poor hygiene standards and practices, and low
quality of complementary foods, could, in this setting, play a
larger role in poor growth than EBF to age 6 mo. Furthermore, it
is likely that mothers in this study population experienced growth
faltering themselves in early life, increasing the risk of an
intergenerational cycle of stunting (31).
What has not received much attention as a potential
contributing factor to poor growth is how entering pregnancy
and lactation with inadequate nutritional status might affect
breast-milk composition (32). It is well established that, regard-
less of maternal BMI, lactating women are capable of producing
sufficient volume and macronutrient concentrations to sustain
infant needs (33, 34). However, limited evidence exists for
breast-milk micronutrient concentrations across the duration of
EBF in mothers who experience nutritional vulnerability (32).
Evidence has shown that several micronutrients in breast milk
are influenced by maternal nutritional status and intake (32),
increasing the need to investigate if low breast-milk micro-
nutrient concentrations could be a contributing factor to the
poor growth experienced in rural Gambia and other low-income
settings. In conclusion, these results suggest that EBF to age 6 mo
has limited benefit to growth in rural Gambia.
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